This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Sep;57(6):917-8.

doi: 10.1093/cid/cit388. Epub 2013 Jun 11.

Reply to Arya and Agarwal

Thomas P C Dorlo, Bart A Ostyn, Jos H Beijnen, Marleen Boelaert, Jean-Claude Dujardin, Suman Rijal

PMID: 23759350
DOI: 10.1093/cid/cit388

Comment

Reply to Arya and Agarwal

Thomas P C Dorlo et al. Clin Infect Dis. 2013 Sep.

. 2013 Sep;57(6):917-8.

doi: 10.1093/cid/cit388. Epub 2013 Jun 11.

Authors

Thomas P C Dorlo, Bart A Ostyn, Jos H Beijnen, Marleen Boelaert, Jean-Claude Dujardin, Suman Rijal

PMID: 23759350
DOI: 10.1093/cid/cit388

No abstract available

PubMed Disclaimer

Comment on

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance.
Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC. Rijal S, et al. Clin Infect Dis. 2013 Jun;56(11):1530-8. doi: 10.1093/cid/cit102. Epub 2013 Feb 20. Clin Infect Dis. 2013. PMID: 23425958
Miltefosine drug concerns.
Arya SC, Agarwal N. Arya SC, et al. Clin Infect Dis. 2013 Sep;57(6):917. doi: 10.1093/cid/cit384. Epub 2013 Jun 11. Clin Infect Dis. 2013. PMID: 23759349 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations